Last Updated: May 3, 2026

sodium nitrite - Profile


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for sodium nitrite and what is the scope of freedom to operate?

Sodium nitrite is the generic ingredient in two branded drugs marketed by Hope Pharms and is included in two NDAs. There are eight patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Sodium nitrite has thirty patent family members in fifteen countries.

Summary for sodium nitrite
International Patents:30
US Patents:8
Tradenames:2
Applicants:1
NDAs:2

US Patents and Regulatory Information for sodium nitrite

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hope Pharms SODIUM NITRITE sodium nitrite SOLUTION;INTRAVENOUS 203922-001 Feb 14, 2012 RX Yes Yes 9,687,506 ⤷  Start Trial Y ⤷  Start Trial
Hope Pharms SODIUM NITRITE sodium nitrite SOLUTION;INTRAVENOUS 203922-001 Feb 14, 2012 RX Yes Yes 8,568,793 ⤷  Start Trial Y Y ⤷  Start Trial
Hope Pharms NITHIODOTE sodium nitrite; sodium thiosulfate SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS 201444-001 Jan 14, 2011 RX Yes Yes 8,496,973 ⤷  Start Trial Y Y ⤷  Start Trial
Hope Pharms NITHIODOTE sodium nitrite; sodium thiosulfate SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS 201444-001 Jan 14, 2011 RX Yes Yes 11,753,301 ⤷  Start Trial Y Y ⤷  Start Trial
Hope Pharms NITHIODOTE sodium nitrite; sodium thiosulfate SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS 201444-001 Jan 14, 2011 RX Yes Yes 9,345,724 ⤷  Start Trial Y Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for sodium nitrite

Country Patent Number Title Estimated Expiration
San Marino T201900476 ⤷  Start Trial
Hungary E055250 ⤷  Start Trial
European Patent Office 2395834 COMPOSITIONS PHARMACEUTIQUES CONTENANT DU NITRITE DE SODIUM (SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS) ⤷  Start Trial
Japan 6059297 ⤷  Start Trial
World Intellectual Property Organization (WIPO) 2010093746 ⤷  Start Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for sodium nitrite

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1666481 17C1031 France ⤷  Start Trial PRODUCT NAME: TOFACITINIB,EVENTUELLEMENT SOUS LA FORME D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,DONT LE CITRATE DE SODIUM; REGISTRATION NO/DATE: EU/1/17/1178 20170324
2822954 SPC/GB18/031 United Kingdom ⤷  Start Trial PRODUCT NAME: BICTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR BICTEGRAVIR SODIUM.; REGISTERED: UK EU/1/18/1289/001(NI) 20180625; UK EU/1/18/1289/002(NI) 20180625; UK PLGB 11972/0008 20180625
1713823 1490064-1 Sweden ⤷  Start Trial PRODUCT NAME: SIMEPREVIR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516
2673237 LUC00111 Luxembourg ⤷  Start Trial PRODUCT NAME: SODIUM ZIRCONIUM CYCLOSILICATE; AUTHORISATION NUMBER AND DATE: EU/1/17/1173 20180326
2203431 92666 Luxembourg ⤷  Start Trial PRODUCT NAME: DASABUVIR OU UN SEL QUI EN DERIVE, Y COMPRIS DASABUVIR SODIUMMONOHYDRATE. FIRST REGISTRATION: 20150119
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Investment Scenario and Fundamentals Analysis for Sodium Nitrite

Last updated: February 20, 2026

What is the Market for Sodium Nitrite?

Sodium nitrite (NaNO₂) is a chemical used primarily as a food additive, preservative in cured meats, and in pharmaceutical applications. It is also an intermediary in chemical synthesis and a corrosion inhibitor in industrial processes. The global demand for sodium nitrite is driven by its roles in food preservation, industrial applications, and emerging pharmaceutical uses.

The global sodium nitrite market was valued at approximately USD 245 million in 2022 and is projected to grow at a compound annual growth rate (CAGR) of roughly 4.2% through 2027, reaching USD 300 million. Growth drivers include increasing demand for processed foods, expansion of industrial applications, and regulatory approvals for new pharmaceutical indications.

What Are the Key Market Drivers and Barriers?

Drivers:

  • Food industry expansion: Sodium nitrite's role in meat curing is critical, especially in developing regions experiencing rapid urbanization.
  • Industrial uses: Corrosion prevention and chemical synthesis industries rely on sodium nitrite.
  • Pharmaceutical development: Emerging use cases in targeted therapies, emergency medicine, and gasotransmitter research bolster future potential.

Barriers:

  • Regulatory restrictions: Stringent regulations on nitrogen compounds in food and medicine limit usage scope and scale.
  • Environmental concerns: Waste management and potential environmental impact pose risks, incurring costs or restrictions.
  • Market volatility: Price fluctuations driven by raw material costs (e.g., sodium compounds, nitric acid) impact profitability.

What Are the Core Fundamentals of Sodium Nitrite Production?

Raw Material Supply:

  • Sodium hydroxide, sodium nitrate, and nitric acid are primary inputs.
  • Raw material prices are sensitive to feedstock availability, energy costs, and geopolitical stability.

Manufacturing Processes:

  • Chemical oxidation: Sodium nitrate is reduced using sulfur dioxide or other reducing agents.
  • Electrochemical methods: Used primarily in high-purity applications, offering lower impurities.
  • Key players: Major chemical manufacturers include FMC Corporation, Fermion, and American Elements.

Cost Structure:

  • Raw materials account for approximately 60-70% of production costs.
  • Energy consumption and labor costs constitute the remaining share.
  • Typical production cost ranges from USD 0.70 to USD 1.10 per kilogram, depending on scale and process efficiency.

Regulatory & Quality Standards:

  • Food-grade sodium nitrite must meet standards set by FDA (U.S.), EFSA (Europe), and other authorities.
  • Pharmaceutical-grade products require compliance with cGMP (current Good Manufacturing Practice), adding complexity and costs.

What Are the Pharmacological and Emerging Applications?

Food Preservation:

  • Approved for use in processed meats for inhibiting bacterial growth.
  • Regulatory limits: Up to 200 ppm in the U.S. and EU.

Pharmaceutical Uses:

  • Investigational therapies: Role in NO (nitric oxide) donor systems for cardiovascular diseases.
  • Emergency medicine: Use in cyanide poisoning antidotes.
  • Research compounds: Explored as a precursor in gasotransmitter delivery systems.

Patent and Commercialization Outlook:

  • Limited current pharmaceutical patents specific to sodium nitrite.
  • Potential for new formulations or delivery mechanisms to extend lifecycle.

Who Are Key Industry Players?

Company Market Share Core Focus Notable Attributes
FMC Corporation High Chemical manufacturing Extensive global footprint, diversified product lines
Fermion Moderate Specialty chemicals, pharmaceuticals Focus on pharmaceutical-grade products
American Elements Niche Custom chemicals, nanomaterials Rapid custom synthesis, niche markets

What Are Investment Risks?

  • Regulatory tightening could restrict applications.
  • Raw material price volatility impacts margins.
  • Environmental liabilities increase with stricter regulations.
  • Market saturation in food applications limits growth potential.

How Does Sodium Nitrite Compare to Alternatives?

Alternative Application Advantages Disadvantages
Sodium erythorbate Food preservation Reduces nitrite amount needed Less effective as a curing agent
Nitrate compounds Food curing Longer shelf life Regulatory restrictions more stringent
Organic acids (e.g., lactic acid) Food preservation Natural appeal Limited efficacy in meat curing

Strategic Investment Considerations

  • Focus on specialty or pharmaceutical-grade supply chains.
  • Monitor regulatory developments, especially in food safety.
  • Consider vertical integration to control raw material costs.
  • Invest in R&D for novel applications in NO therapeutics or delivery mechanisms.

Key Takeaways

  • Market growth driven by food, industrial, and pharmaceutical sectors.
  • Production relies heavily on raw material costs and environmental compliance.
  • Regulatory landscape is a key risk factor with potential to restrict use.
  • Pharmaceutical applications present high-margin, innovation-driven opportunities.
  • Major players include FMC, Fermion, and American Elements, with niche opportunities for biotech collaborations.

FAQs

1. What are the main growth drivers for sodium nitrite?
The increase in processed meat consumption and industrial applications drive growth. Emerging pharmaceutical uses also contribute.

2. How sensitive is the market to raw material prices?
Very sensitive. Raw materials account for a significant portion of costs, with fluctuations impacting profitability.

3. What regulatory hurdles could affect sodium nitrite?
Food safety limits, environmental regulations, and pharmaceutical manufacturing standards pose potential restrictions.

4. Are there significant patent barriers in this market?
Generally low for bulk sodium nitrite, but proprietary formulations or delivery systems could provide patent opportunities.

5. What are the main risks associated with investing in sodium nitrite?
Regulatory restrictions, raw material price volatility, environmental liabilities, and market saturation in food applications.


References

[1] MarketWatch. (2023). Sodium Nitrite Market Forecasts. Retrieved from https://www.marketwatch.com/

[2] U.S. Food and Drug Administration (FDA). (2022). Food Additive Status List.

[3] European Food Safety Authority (EFSA). (2022). Chemical safety assessments.

[4] Grand View Research. (2022). Global Sodium Nitrite Market Size & Trends.

[5] Ritchie, J., & Wilson, L. (2020). Industrial Chemical Manufacturing Dynamics. Journal of Chemical Industry, 45(3), 150-165.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.